Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026)
Axsome Therapeutics (AXSM) reported Current Taxes of $99000.0 for Q1 2026, down 89.69% on a YoY basis from $960000.0 in Q1 2025, and down 1.98% sequentially from $101000.0 in Q4 2025.
Axsome Therapeutics (AXSM) Current Taxes (2024 - 2026) Analysis & Trends
Axsome Therapeutics (AXSM) has 3 years of Current Taxes data on file, last reported at $99000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes fell 89.69% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $99000.0 (down 89.69% YoY), and the FY2025 full-year result was $101000.0, down 89.48% from the prior year.
- Current Taxes declined to $99000.0 in Q1 2026, from $101000.0 in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $960000.0 in Q4 2024 to a low of $99000.0 in Q1 2026.
- A 3-year average of $514000.0 and a median of $493000.0 in 2024 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes surged 95.12% in 2025 and slumped 89.69% in 2026, its largest moves.
- Tracing AXSM's Current Taxes over 3 years: stood at $960000.0 in 2024, then sank by 89.48% to $101000.0 in 2025, then fell by 1.98% to $99000.0 in 2026.
- Business Quant data shows AXSM's Current Taxes at $99000.0 in Q1 2026, $101000.0 in Q4 2025, and $960000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.58 Bn | 466.79 Bn | 1.35 Bn | 63.52 Mn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.80 Bn | 50.61 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | - |
| 10 | Axsome Therapeutics | 12.27 Bn | 11.97 Bn | 176.48 Mn | 99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99,000.00 |
| Dec 31, 2025 | 101,000.00 |
| Mar 31, 2025 | 960,000.00 |
| Dec 31, 2024 | 960,000.00 |
| Sep 30, 2024 | 493,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Mar 31, 2024 | 492,000.00 |